Independent Portfolio Consultants’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | $143K | Sell |
1,887
-606
| -24% | -$45.9K | 0.06% | 351 |
|
|
2017
Q1 | $165K | Buy |
2,493
+24
| +1% | +$1.59K | 0.06% | 361 |
|
|
2016
Q4 | $156K | Sell |
2,469
-56
| -2% | -$3.54K | 0.05% | 365 |
|
|
2016
Q3 | $161K | Buy |
2,525
+104
| +4% | +$6.63K | 0.05% | 376 |
|
|
2016
Q2 | $180K | Buy |
2,421
+2,261
| +1,413% | +$168K | 0.06% | 354 |
|
|
2016
Q1 | $11K | Buy |
160
+48
| +43% | +$3.3K | ﹤0.01% | 714 |
|
|
2015
Q4 | $8K | Buy |
+112
| New | +$8K | ﹤0.01% | 725 |
|
|
2015
Q3 | – | Sell |
-104
| Closed | -$7K | – | 838 |
|
|
2015
Q2 | $7K | Buy |
+104
| New | +$7K | ﹤0.01% | 790 |
|
|
2014
Q4 | – | Sell |
-4,609
| Closed | -$135K | – | 906 |
|
|
2014
Q3 | $135K | Buy |
+4,609
| New | +$135K | 0.04% | 513 |
|